WuXi Vaccines and BravoBio collaborate to accelerate innovative vaccines

The CDMO will provide expertise and capacity to advance BravoBio's vaccine pipeline

The recent outbreaks and epidemics have highlighted the importance of industrial collaboration and partnership. And now, WuXi Vaccines, a joint venture between WuXi Biologics and Shanghai Hile Bio-Technology focused on vaccine CDMO services, and Shanghai BravoBio have signed a Letter of Intent for long-term collaboration on accelerating the development and commercial manufacturing of innovative vaccines.

Specifically, the collaboration will focus on using WuXi Vaccines' end-to-end vaccine development and manufacturing capabilities to advance BravoBio's vaccine pipeline, which aims to address challenges from infectious diseases.

The partnership will see BravoBio utilise WuXi Vaccines’ integrated platforms to conduct preclinical research, GMP manufacturing of clinical supply and global commercial supply for its multiple innovative vaccine candidates.

In addition, the CDMO will leverage its experience and capacity to support the Investigational New Drug (IND) application and commercialication for BravoBio’s vaccine products globally.

Back in November 2019, WuXi Vaccines announced it was investing $240 million and building a new vaccine manufacturing facility in Dundalk, Ireland. The facility got underway in February 2020 and is due to be operational by 2024.

Related categories

Contract Manufacturing Contract Services - Contract Services Vaccines Antiinfectives for Systemic use

Related News

News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma

The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024.

30 Jan 2024
News Women in Pharma: Minding the Gap at Pharmapack 2024

2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused...

29 Jan 2024
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation

The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles.

24 Jan 2024
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures

The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year.

9 Jan 2024
News New Novo Nordisk AI hub for drug discovery to open in London, UK

Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations.

5 Jan 2024
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025

German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa.

20 Dec 2023
News Women in Pharma: Looking back on 2023 and moving forward to 2024

In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond.

19 Dec 2023
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations

During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.

18 Dec 2023